MedTrace Logo

Virtual Reality in Orthopaedic Surgical Education: A Randomized Controlled Trial

NCT05830786 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-04-26

No results posted yet for this study

Summary

Immersive virtual reality (IVR) surgical simulators are increasingly being used for learner education. The aim of this randomized controlled trial is to compare the efficacy of IVR to hands-on orthopaedic workshop sessions (such as arthroscopy simulators, cadaveric models, and Sawbones®) in various orthopaedic subspecialties (such as sports, arthroplasty, and spine surgery).

Overall, in this multi-stage comprehensive randomized controlled the aim is to assess:

1. If IVR simulation using head-mounted displays (HMD) is superior to the current standard of training for orthopaedic surgery residents and medical students.
2. Determine if it is feasible to incorporate immersive headset virtual reality simulation into residency training programs and medical school curriculums.
3. Assess the longitudinal application of IVR training on medical student and resident surgical education.

Conditions

  • Surgical Education
  • Virtual Reality
  • Orthopaedic Training

Interventions

DEVICE

Immersive virtual reality (IVR)

Using Oculus Quest 2 (Reality Labs, Meta Platforms, United States) headsets the PrecisionOS platform version 3.0 (PrecisionOS Technology, Canada) virtual reality surgical modules will be utilized.

OTHER

Traditional hands on orthopaedic workshop group

Hands-on orthopaedic workshop sessions (including arthroscopy simulators, cadaveric models, and Sawbones®) in differing orthopaedic subspecialties (including sports, arthroplasty, and spine surgery).

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Principal Investigators

  • Jesse Wolfstadt, MD · University of Toronto

  • Peter Ferguson, MD · University of Toronto

  • Johnathan R Lex, MB ChB · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-16
Primary Completion
2023-09-01
Completion
2024-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05830786 on ClinicalTrials.gov